Auf dieser Website kommen Cookies zum Einsatz. Für weitere Informationen über Cookies, klicken Sie bitte auf den Link Datenschutz. Wenn Sie „Ok“ klicken und die Website weiter nutzen, gehen wir von Ihrem Einverständnis aus.

Cookies are used on this website. For more information about cookies, please click on the Privacy Policy link. If you click on "Ok" and continue to use the website, we assume your agreement.

New approaches and tools to maximize success on the journey from research product to the clinic


Tuesday, June 19, 2018
IZB, Munich, Germany
Biologic drug substance are increasingly complex, creating numerous difficulties for biopharmaceutical companies
from higher candidate failure rates to expression and manufacturing challenges. Please join us on Tuesday, 19 June at IZB in Munich for a complimentary symposium on approaches to address these challenges in early biopharmaceutical development. Gain insight from subject matter experts on different techniques to successfully progress therapeutic proteins from late discovery to the clinic. Topics include:

- De‐risking strategies for candidate selection
- New technologies for the expression of complex proteins
- Services for clinical development and manufacturing

Case studies will be presented.

After a networking lunch, take advantage of the afternoon Lonza “Ask the Expert” Clinic where you’ll have the
opportunity to reserve a one‐on‐one session with a subject matter expert for advice and tips on a development
challenge you are facing.

Apply to attend
- Attendance at this event is complimentary and by invitation
- Please register at
You will receive an email confirming your registration

Venue details
IZB, Fördergesellschaft IZB GmbH
Am Klopferspitz 19
82152 Planegg/Martinsried, Munich
Tel: +49 (0) 89 ‐ 552 79 48‐0
Insight and discussion with our experts

08:30 – 09:00 Delegate Registration, Breakfast
09:00 – 09:10 Welcome
09:10 – 10:00 Yvette Stallwood, Ph.D. Head of Applied Protein Services, Lonza Pharma & Biotech
Early developability assessment tools and successful de‐risking strategies to support progression of biologics from discovery to clinical development
10:00 – 11:00 Andy Racher, Ph.D. Principal Scientist, Future Technologies, Lonza Pharma & Biotech
Expression tools for the rapid development of high‐yielding and stable mammalian cell lines and microbial strains for late discovery to the clinic and beyond
11:00 – 11:15 Break, networking over tea and coffee
11:15 – 12:00 Julia Neugebauer, Director, Discovery Alliances Technologies, Morphosys AG
Tools and strategies for successful antibody discovery
12:00 – 12:30 Dimor Elbers, Business Development, EU region, Lonza Pharma & Biotech
Lonza clinical development and manufacturing services ‐ An overview
12:30 – 13:30 Networking Lunch (provided)
13:30 – 15:00 Lonza Ask‐the Expert Clinic
Our experts will be on hand for one‐on‐one sessions to answer your questions about
development challenges you are facing
15:00 – 15:30 Networking tea and coffee ‐ Delegates depart

Download Programm im PDF-Format